Charles Schwab Investment Management Inc. grew its holdings in shares of Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 5.3% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 439,796 shares of the semiconductor company's stock after purchasing an additional 21,991 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 1.36% of Silicon Laboratories worth $54,631,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also recently made changes to their positions in the business. Jones Financial Companies Lllp increased its position in Silicon Laboratories by 44.5% in the fourth quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company's stock worth $28,000 after buying an additional 69 shares in the last quarter. Advisors Asset Management Inc. raised its stake in Silicon Laboratories by 159.4% during the 3rd quarter. Advisors Asset Management Inc. now owns 275 shares of the semiconductor company's stock worth $32,000 after acquiring an additional 169 shares during the period. Venturi Wealth Management LLC lifted its holdings in Silicon Laboratories by 207.0% during the fourth quarter. Venturi Wealth Management LLC now owns 786 shares of the semiconductor company's stock valued at $98,000 after purchasing an additional 530 shares in the last quarter. Asset Management One Co. Ltd. bought a new position in shares of Silicon Laboratories in the fourth quarter worth approximately $117,000. Finally, KBC Group NV boosted its position in shares of Silicon Laboratories by 42.1% in the fourth quarter. KBC Group NV now owns 1,279 shares of the semiconductor company's stock worth $159,000 after purchasing an additional 379 shares during the period.
Analysts Set New Price Targets
A number of equities research analysts have commented on the company. Needham & Company LLC reissued a "buy" rating and set a $150.00 price target on shares of Silicon Laboratories in a report on Wednesday, March 12th. Barclays upped their price target on Silicon Laboratories from $75.00 to $120.00 and gave the stock an "equal weight" rating in a research note on Friday, January 17th. Stifel Nicolaus lifted their price objective on shares of Silicon Laboratories from $135.00 to $145.00 and gave the company a "buy" rating in a research report on Monday, January 6th. KeyCorp upped their target price on shares of Silicon Laboratories from $115.00 to $160.00 and gave the stock an "overweight" rating in a research report on Wednesday, January 22nd. Finally, StockNews.com downgraded shares of Silicon Laboratories from a "hold" rating to a "sell" rating in a report on Friday, February 28th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $136.20.
Check Out Our Latest Report on SLAB
Silicon Laboratories Stock Performance
Shares of NASDAQ:SLAB traded up $2.41 on Monday, reaching $126.66. The company's stock had a trading volume of 234,971 shares, compared to its average volume of 302,145. The company has a 50-day simple moving average of $138.51 and a 200 day simple moving average of $122.88. Silicon Laboratories Inc. has a 52-week low of $94.00 and a 52-week high of $160.00. The company has a market cap of $4.11 billion, a P/E ratio of -21.32 and a beta of 1.15.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) EPS for the quarter, hitting the consensus estimate of ($0.11). Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The company had revenue of $166.25 million during the quarter, compared to analyst estimates of $166.09 million. During the same quarter last year, the business posted ($1.19) earnings per share. The firm's revenue was up 91.4% on a year-over-year basis. On average, equities research analysts forecast that Silicon Laboratories Inc. will post -0.97 EPS for the current fiscal year.
Insider Activity
In related news, Director William G. Bock sold 1,000 shares of Silicon Laboratories stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $149.43, for a total transaction of $149,430.00. Following the completion of the transaction, the director now directly owns 31,115 shares of the company's stock, valued at approximately $4,649,514.45. The trade was a 3.11 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Navdeep S. Sooch sold 2,360 shares of the stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $149.00, for a total transaction of $351,640.00. Following the completion of the sale, the director now directly owns 400,567 shares in the company, valued at $59,684,483. This trade represents a 0.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 5,360 shares of company stock valued at $782,610. 1.72% of the stock is currently owned by insiders.
Silicon Laboratories Company Profile
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Read More

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report